Shennon Biotechnologies
Develops a single-cell platform for rapid immunotherapy drug discovery.
biotechpharmaceuticals
Company facts
Seed-stage
- Founded
- 2021
- Employees
- 16
- Headquarters
- United States
- Type
- Private
- Funding
- Seed · $13M · 2023
Open positions
1 job
12 views 2 weeks ago
CMC Lead, Multispecific Antibodies (Director level, consulting)
Open 18d RemoteNorth AmericaFull-timeLead No extra questions
United States
San Francisco, CA (remote considered)About Us Shennon Biotechnologies is developing precision immunotherapies for solid tumors through an integrated technology platform spanning target discovery, ultra-high-throughput microfluidics-driven functional…